Similar articles

• [Use of a microfiltration method in producing inactivated influenza vaccine].

  Ivanov NB, Zhemkov VP, Gromov VI, Cherkasov AN, Shashkov LA. Ivanov NB, et al. Vopr Virusol. 1986 Jul-Aug;31(4):404-9. Vopr Virusol. 1986. PMID: 3765563 Russian.
• [Laboratory control of the purity of chromatographic influenza vaccine].

  Bichurina MA, Goriunova VV, Zhebrun AB, Chubarova NI. Bichurina MA, et al. Tr Inst Im Pastera. 1979;52:121-8. Tr Inst Im Pastera. 1979. PMID: 121646 Russian. No abstract available.
• [Obtaining a lyophilized preparation of inactivated influenza vaccine].

  Goriunova VV, Bichurina MA, Gerasimov VA. Goriunova VV, et al. Tr Inst Im Pastera. 1979;52:110-4. Tr Inst Im Pastera. 1979. PMID: 550533 Russian. No abstract available.
• Influenza vaccines: from whole virus preparations to recombinant protein technology.

  Huber VC. Huber VC. Expert Rev Vaccines. 2014 Jan;13(1):31-42. doi: 10.1586/14760584.2014.852476. Expert Rev Vaccines. 2014. PMID: 24192014 Review.
• Influenza vaccine: Where are we and where do we go?

  Keshavarz M, Mirzaei H, Salemi M, Momeni F, Mousavi MJ, Sadeghalvad M, Arjeini Y, Solaymani-Mohammadi F, Sadri Nahand J, Namdari H, Mokhtari-Azad T, Rezaei F. Keshavarz M, et al. Rev Med Virol. 2019 Jan;29(1):e2014. doi: 10.1002/rmv.2014. Epub 2018 Nov 8. Rev Med Virol. 2019. PMID: 30408280 Review.